Unanticipated improvement in seizure control in drug-resistant epilepsy-real world observations

被引:5
作者
Moloney, Patrick B. [1 ]
Costello, Daniel J. [1 ,2 ]
机构
[1] Cork Univ Hosp, Dept Neurol, Cork, Ireland
[2] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
来源
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 2021年 / 84卷
关键词
Drug-resistant epilepsy; Anti-seizure medication; Unanticipated treatment response; Rational polytherapy; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; ILAE COMMISSION; REMISSION; POPULATION; LACOSAMIDE; OUTCOMES; SURGERY; RELAPSE;
D O I
10.1016/j.seizure.2020.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine the clinical features and anti-seizure medication (ASM) strategies associated with an unanticipated substantial improvement in seizure control in patients with drug-resistant epilepsy (DRE). Methods: This retrospective analysis of patients attending a tertiary care epilepsy clinic between 2008 and 2017 identified all patients with active DRE (at least 1 seizure per month for 6 months, despite treatment with 2 different ASMs). All treatment interventions were recorded from when DRE was first identified to the end of the study. The primary end points were seizure freedom or meaningful reduction in seizure frequency (greater than 75 %) sustained for at least 12 months after a treatment intervention. Results: Three hundred and twenty-two patients were included in the analysis. Overall, 10 % became seizure free following ASM adjustment and an additional 10 % had a greater than 75 % improvement in seizure control (median follow-up, 4 years). An ASM introduction was ten times more likely than an ASM dose increase to improve seizure control. Combined focal and generalized epilepsy, intellectual disability and prior treatment with more than 5 ASMs were more frequently observed in those with continued pharmacoresistance. ASM responders were more likely to have primary generalized epilepsy. Rational polytherapy (combining ASMs with different mechanisms of action) was almost ubiquitous amongst ASMs responders (95 % taking at least 2 drugs with different mechanistic targets). Of the ASM additions that heralded improved seizure control, 85 % were maintained at submaximal doses. Conclusions: This retrospective analysis of a large number of 'real-world' patients provides evidence to persist with ASM trials in DRE. Early rotation of ASMs if a clinical response is not observed at a substantial dose and rational ASM polytherapy may yield better clinical outcomes in patients with DRE, although a prospective study would need to be conducted to validate these findings.
引用
收藏
页码:60 / 65
页数:6
相关论文
共 34 条
  • [1] Clinical utility of therapeutic drug monitoring of antiepileptic drugs Systematic review
    Al-Roubaie, Zanab
    Guadagno, Elena
    Ramanakumar, Agnihotram V.
    Khan, Afsheen Q.
    Myers, Kenneth A.
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (04) : 344 - 355
  • [2] European trends in epilepsy surgery
    Baud, Maxime O.
    Perneger, Thomas
    Racz, Attila
    Pensel, Max C.
    Elger, Christian
    Rydenhag, Bertil
    Malmgren, Kristina
    Cross, J. Helen
    McKenna, Grainne
    Tisdall, Martin
    Lamberink, Herm J.
    Rheims, Sylvain
    Ryvlin, Philippe
    Isnard, Jean
    Mauguiere, Francois
    Arzimanoglou, Alexis
    Akkol, Serdar
    Deniz, Kaancan
    Ozkara, Cigdem
    Lossius, Morten
    Rektor, Ivan
    Kalviainen, Reetta
    Vanhatalo, Lotta-Maria
    Dimova, Petia
    Minkin, Krassimir
    Staack, Anke Maren
    Steinhoff, Bernhard J.
    Kalina, Adam
    Krsek, Pavel
    Marusic, Petr
    Jordan, Zsofia
    Fabo, Daniel
    Carrette, Evelien
    Boon, Paul
    Rocka, Saulius
    Mameniskiene, Ruta
    Vulliemoz, Serge
    Pittau, Francesca
    Braun, Kees P. J.
    Seeck, Margitta
    [J]. NEUROLOGY, 2018, 91 (02) : E96 - E106
  • [3] Seizure severity is associated with quality of life independent of seizure frequency
    Bautista, Ramon Edmundo D.
    Glen, E. Tannahill
    [J]. EPILEPSY & BEHAVIOR, 2009, 16 (02) : 325 - 329
  • [4] Prognostic patterns and predictors in epilepsy: a multicentre study (PRO-LONG)
    Beghi, Ettore
    Beretta, Simone
    Carone, Davide
    Zanchi, Clara
    Bianchi, Elisa
    Pirovano, Marta
    Trentini, Claudia
    Padovano, Giada
    Colombo, Matteo
    Cereda, Diletta
    Scanziani, Sofia
    Giussani, Giorgia
    Gasparini, Sara
    Bogliun, Graziella
    Ferrarese, Carlo
    Romeo, A.
    Milano, Lodi M.
    Novara, Viri M.
    Specchio, L.
    Foggia, Trivisano M.
    Mecarelli, O.
    Roma, Zarabla A.
    Capovilla, G.
    Mantova, Beccaria F.
    Melegnano, Sasanelli F.
    Galimberti, C. A.
    Pavia, Tartara E.
    Zamponi, N.
    Ancona, Cappanera S.
    Catanzaro, Aguglia U.
    Calabria, Ferlazzo E. Reggio
    La Neve, A.
    Luisi, C.
    Bari, Pontrelli G.
    Basso, P.
    Gallarate, Pozzi A.
    Cantisani, A. T.
    Perugia, Papetti R.
    Brescia, De Maria G.
    Monza, Di Francesco J.
    Milano, Albanese J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (11) : 1276 - 1285
  • [5] Patterns of treatment response in newly diagnosed epilepsy
    Brodie, M. J.
    Barry, S. J. E.
    Bamagous, G. A.
    Norrie, J. D.
    Kwan, P.
    [J]. NEUROLOGY, 2012, 78 (20) : 1548 - 1554
  • [6] Combining antiepileptic drugs-Rational polytherapy?
    Brodie, Martin J.
    Sills, Graeme J.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (05): : 369 - 375
  • [7] Remission and relapse in a drug-resistant epilepsy population followed prospectively
    Callaghan, Brian
    Schlesinger, Malka
    Rodemer, William
    Pollard, John
    Hesdorffer, Dale
    Hauser, W. Allen
    French, Jacqueline
    [J]. EPILEPSIA, 2011, 52 (03) : 619 - 626
  • [8] Likelihood of seizure remission in an adult population with refractory epilepsy
    Callaghan, Brian C.
    Anand, Kishlay
    Hesdorffer, Dale
    Hauser, W. Allen
    French, Jacqueline A.
    [J]. ANNALS OF NEUROLOGY, 2007, 62 (04) : 382 - 389
  • [9] Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
    Chen, Zhibin
    Brodie, Martin J.
    Liew, Danny
    Kwan, Patrick
    [J]. JAMA NEUROLOGY, 2018, 75 (03) : 279 - 286
  • [10] Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications
    Choi, Hyunmi
    Hayat, Matthew J.
    Zhang, Ruiqi
    Hirsch, Lawrence J.
    Bazil, Carl W.
    Mendiratta, Anil
    Kato, Kenneth
    Javed, Asif
    Legge, Alexander W.
    Buchsbaum, Richard
    Resor, Stanley
    Heiman, Gary A.
    [J]. EPILEPSIA, 2016, 57 (07) : 1152 - 1160